Description
GLOW Blend is a multi-component research formulation combining three peptides frequently studied together in preclinical tissue-repair models: BPC-157, a pentadecapeptide investigated for cytoprotective and angiogenic activity; TB-500, a fragment of thymosin beta-4 studied for actin regulation and cell migration; and GHK-Cu, a copper-binding tripeptide examined for extracellular matrix remodeling. It is provided as a combined tool preparation for investigating their interacting signaling endpoints in experimental designs.
GLOW Blend has been examined in preclinical in vitro and rodent model studies of angiogenesis, collagen and extracellular matrix synthesis, cell migration, inflammatory signaling, and wound-healing dynamics. Its combined formulation supports comparative and additive-effect research across the tissue-repair pathways associated with its constituent peptides in cell-based and rodent models.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.